Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma

British Journal of Dermatology

Volumn 146, Issue 2, 2002, Pages 244-249

  Hochberg, M ^a   Lotem, M ^a   Gimon, Z ^a   Shiloni, E ^b   Enk, C D ^a  

^a HEBREW UNIVERSITY   (Israel)

^b CARMEL MEDICAL CENTER   (Israel)

Author keywords

Melanoma markers; Micrometastases; Reverse transcriptase polymerase chain reaction; Sentinel lymph nodes

Indexed keywords

MELAN A; MESSENGER RNA; MONOPHENOL MONOOXYGENASE; PROTEIN; PROTEIN MIA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; MELANOMA; MELANOMA CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE;

ADULT; ANTIGENS, NEOPLASM; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 0036211285     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04579.x     Document Type: Article

References (29)

1. Polymerase chain reaction in the detection of micrometastases and circulating tumor cells
2. Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors
3. Detection of early micrometastases in malignant melanoma
4. Prognostic factors for response and survival in patients with metastatic melanoma receiving immunotherapy
5. Polymerase chain reaction for detection of melanoma in peripheral blood: Too early to assess clinical value
6. Heterogeneity of clones from human metastatic melanoma detected by autologous cytotoxic T-lymphocyte clones
7. The role of genetic instability, adhesion, cell motility immune escape mechanisms in melanoma expression
8. Molecular genetics of human malignant melanoma
9. Antigenic profile of tumor progression stages in human melanocyte nevi and melanomas
10. Melanoma-associated antigens as messenger RNA detection markers for melanoma
11. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay
12. Reproducibility of detection of tyrosinase and MART-1 transcript in the peripheral blood of melanoma patients: A quality control study using real-time quantitative RT-PCR
13. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases
14. Analysis of mammalian pigmentation at the molecular level
15. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction
16. Cloning of a new malignant melanoma-derived growth regulatory protein, MIA
17. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
18. Cutaneous melanoma: Pathology, relevant prognostic indicators and progression
19. Cutaneous melanoma
20. Lymphatic drainage of skin to a sentinel lymph node in a feline model
21. Technical details of intraoperative lymphatic mapping for early stage melanoma
22. Intraoperative lymphatic mapping using patent blue V dye to identify nodal micro-metastases in malignant melanoma
23. Detection of melanoma micrometastases in the sentinel lymph node and in nonsentinel nodes by tyrosinase polymerase chain reaction
24. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma
25. Molecular staging of malignant melanoma. Correlation with clinical outcome
26. Detection of melanoma micrometastasis in sentinel nodes by reverse transcription-polymerase chain reaction correlates with tumor thickness and is predictive of micrometastatic disease in the lymph node basin
27. Minimally invasive staging of patients with melanoma: Sentinel lymphadenectomy and detection of the melanoma-specific proteins MART-1 and tyrosinase by reverse transcriptase polymerase chain reaction
28. Molecular and cellular changes associated with the acquisition of metastatic ability by prostatic cancer cells